[268 Pages Report] The global Excimer and Femtosecond Ophthalmic Lasers Market size reached US$ 1.02 billion in 2021 and is expected to touch a valuation of US$ 1.18 billion by the end of 2022. Furthermore, with the increasing prevalence of eye diseases across the world and growing adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise at 8.0% CAGR over the forecast period (2022 to 2032), totaling a market valuation of US$ 2.41 billion by 2032.
By application, the refractive surgeries segment dominated the global Excimer and Femtosecond Ophthalmic Lasers Market with a total value share of nearly 69% in 2021.
An excimer laser is a form of ultraviolet laser, commonly used in ophthalmic surgeries. The most common procedures conducted using this laser are excimer laser photorefractive keratectomy and excimer laser in-situ keratomileusis (LASIK), which can be used to correct refractive errors of the eye, as excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea.
Attribute | Key Statistics |
---|---|
Excimer and Femtosecond Ophthalmic Lasers Market Base Value (2021) | US$ 1.02 billion |
Estimated Market Value (2022) | US$ 1.18 billion |
Projected Market Value (2032) | US$ 2.41 billion |
Value-based CAGR of (2022 to 2032) | 8.0% |
Market share of Top 5 countries | 56.5% |
The femtosecond (FS) laser is an infrared laser with a wavelength of 1053nm. These lasers fall under the category of ultrafast lasers or ultra-short pulse lasers. Shortened pulse duration reduces the amount of collateral tissue damage, which makes FS laser safe for use in corneal surgeries owing to the need for higher precision. Both these lasers play a significant role in refractive, cataract surgeries, and other ophthalmic surgeries.
Excimer and femtosecond ophthalmic lasers have become highly sought-after products used in surgical care for treating numerous eye disorders on account of their safe, precise, and accurate nature. With these attractive benefits and advancements in their technologies, excimer and femtosecond ophthalmic lasers have the potential to become the gold standard of eye surgeries.
Rise prevalence of various eye disorders such as glaucoma, macular degeneration, and diabetic retinopathy along with a surge in the number of eye surgeries performed worldwide is expected to bolster the growth of the Excimer and Femtosecond Ophthalmic Lasers Market during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global Excimer and Femtosecond Ophthalmic Lasers Market is expected to expand at 8.0% CAGR in terms of revenue over the forecast period (2022 to 2032), in comparison to the 7.5% CAGR registered from 2014 to 2021.
The growth of the global excimer & femtosecond ophthalmic lasers market is mainly driven by the increasing diabetic and aging population globally. This increase is resulting in a rise in the number of common ophthalmic disorders such as cataracts, glaucoma, etc.
Other prominent growth factors include an increasing number of refractive errors such as myopia (moderate to high myopia) seen in younger persons and an increasing inclination towards LVC (Laser Vision Correction) procedures.
As per the Centers for Disease Control and Prevention (CDC), around 12 million people aged 40 years and older in the United States have vision impairment and this number is expected to further surge during the forthcoming years.
The increasing prevalence of age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy, and presbyopia require surgical correction to restore normal vision. Thus, the increasing aging and diabetic population is a major factor expected to fuel the growth of the global Excimer and Femtosecond Ophthalmic Lasers Market over the forecast period.
Similarly, patients’ rising awareness of curative ophthalmic health is creating sustainable demand for ophthalmic treatments globally. Patients particularly in countries such as India, The United Kingdom, Canada, and The USA tend to search for adequate ophthalmic treatments over the internet.
This along with the development in ophthalmic surgical infrastructure has thus led to an increasing number of ophthalmic surgeries in emerging economies, involving advanced technologies such as femtosecond lasers and excimer lasers over the last few years and the trend is likely to continue during the forecast period.
Improving Access to Eye Care Services Due to Rise in the Number of Ophthalmology Hospitals and Clinics Bolstering Market Growth
More ophthalmology clinics and hospitals are being established in many nations throughout the world. This is due to the large numbers of older people visiting ophthalmology clinics and hospitals as well as the large numbers of diabetic people who have eye disease or are at risk of developing it. This is anticipated to support femtosecond and excimer ophthalmic laser market growth during the next ten years.
The government and other regulatory bodies are putting greater efforts to make eye care services an integral part of universal health coverage and address the rising impact of vision loss on sustainable development. This will create lucrative growth prospects within the global excimer and femtosecond laser market.
To provide ophthalmologists with the best tools possible for performing delicate eye procedures, ophthalmic laser manufacturers are constantly improving their laser systems.
Femtosecond laser cutting is done with greater precision and accuracy when compared to manual surgery. Femto laser cutting provides more safety, consistency, predictability, and flexibility for LASIK surgery.
Bladeless LASIK using excimer and femtosecond lasers reduces the risk of incomplete or irregular cutting as well as the possibility of free caps. Since more businesses are obtaining patents for their technological advancements, it is projected that greater acceptance of femtosecond technology in ophthalmology will lead to an increase in the number of players in the worldwide femtosecond lasers market.
Additionally, LASIK and other laser eyes surgeries, such as PRK and LASEK, have very high success rates and outstanding safety features, creating tremendous potential for ophthalmic laser producers during the projected period.
Femto-LASIK surgery includes certain complications, such as drying of the eyes because some nerves may get injured, affecting tear production.
Additionally, in some cases of flap margin necrosis, a patient may experience a stinging sensation in the eyes. Opacified bubble layer, extreme light sensitivity, partial flaps, rainbow glare, torn flap, corneal perforation, incomplete flap, decentred flaps, small flaps, slipped flaps, flap-folds, traumatic flap dislocation, optic nerve damage, flap tears, haze, macular hemorrhage, infection, stromal cell necrosis, inflammation, and corneal nerve damage are additional uncommon complications.
Furthermore, the high price of femtosecond laser systems hinders their use in developing nations. A femtosecond laser system typically costs approximately US$ 500,000, with service fees of about 10% annually and a per-use fee of about US$ 350 to US$ 450 per eye. The expense of refractive and femtosecond refractive surgeries rises as a result of the femtosecond surgical method, which is ultimately reflected in the expensive pricing. As a result, the majority of people in emerging nations who have refractive defects prefer traditional Lasik treatments, such as LASIK with microkeratomes, for refractive surgery.
Thus, the high cost of these systems and such common and uncommon complications related to the treatments are anticipated to restrain the growth of the worldwide Excimer and Femtosecond Ophthalmic Lasers Market during the forecast period.
Increase in Minimally Invasive Eye Surgeries Driving Market in The USA
The USA held the largest market share of about 81.8% of the North American Excimer and Femtosecond Ophthalmic Lasers Market in 2021 and it is poised to grow at a robust pace during the next ten years.
Excimer and Femtosecond Ophthalmic Lasers Market expansion is anticipated to be fuelled by FDA clearance for femtosecond lasers in the USA, increasing spending on eye care, and the presence of well-established ophthalmic laser manufacturers in the nation.
Similarly, the growing popularity of minimally invasive glaucoma surgery and the availability of advanced technologies are playing crucial roles in expanding the USA Excimer and Femtosecond Ophthalmic Lasers Market.
Additionally, growing cases of cataract patients and a preference for high-end products with reduced risk factors post-surgery amongst the American population are further expected to boost this market growth over the forecast duration.
According to the Centers for Disease Control and Prevention (CDC), over one million cataract surgeries are performed each year in The USA and more than half of Americans over the age of 80 are living with cataracts. This will continue to push the demand for excimer and femtosecond ophthalmic lasers in The USA during the forecast period.
Rise in Eye Diseases Boosting Sales of Ophthalmic Lasers in Spain
As per FMI, Spain accounted for around 22.3% share of the European Excimer and Femtosecond Ophthalmic Lasers Market in 2021 and is expected to generate revenue worth US$ 40.5 Million in 2022. Growth in Spain’s Excimer and Femtosecond Ophthalmic Lasers Market is driven by the rising prevalence of eye disorders such as myopia in children, especially between the age group 5-7 years, expansion of the healthcare industry, and favorable government support.
The surge in Geriatric Population and Growing preference for laser Operations Pushing Demand in Japan
As of 2021, the excimer and femtosecond lasers market in Japan reached a valuation of US$ 56.8 Million and it is expected to witness a healthy growth rate during the next ten years. Given that laser operations and ophthalmic lasers offer far greater safety and effectiveness than conventional methods, the significant prevalence of an aging population in the nation is driving up demand for these procedures and devices.
For instance, using a femtosecond laser during cataract surgery enables the surgeon to cut the cornea and open the lens capsule in addition to fragmenting the cataract. This reduces heat harm to ocular tissues caused by ultrasound and corneal oedema and low-energy phacoemulsification.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Excimer Laser Remains the Highly Sought-After Product in the Market
Based on product, the excimer lasers segment dominated the global excimer and femtosecond ophthalmic lasers market with a total market share of about 60.3% in 2021 and it is likely to grow at a higher CAGR during the forecast period.
This can be attributed to the rising usage of excimer lasers in ophthalmic surgery on account of their safe and highly effective nature. These lasers have ultraviolet wavelengths that are used for the photodecomposition of tissue and ablation.
Excimer laser treatment methods include excimer laser in situ keratomileusis and photorefractive keratectomy for the correction of ocular refractive defects.
Although they can also be used to treat astigmatism and hyperopia (farsightedness), myopia (near-sightedness) is the condition they are most frequently used.
Demand for Ophthalmic Lasers Remains High in Refractive Surgeries
The refractive surgery segment held the largest revenue share of around 69.7% in 2021 and it is likely to remain the most lucrative application for excimer and femtosecond ophthalmic lasers during the forecast period.
Increasing incidence of refractive errors along with the rise in the number of refractive surgeries to eliminate or reduce the dependence on glasses and contact lenses are driving the growth of this segment.
According to the World Health Organisation (WHO), an estimated 153 million people get visually impaired due to uncorrected refractive error worldwide. The rising prevalence of far-sightedness & near-sightedness and awareness campaigns for visual abnormalities are some major factors leading to the demand for refractive surgeries that will eventually boost the market growth.
Most of the Demand arises from Ophthalmic Clinics
By end user, ophthalmology clinics dominated the global excimer and femtosecond lasers market with a share of about 44.7% in 2021 and the trend is likely to continue during the forecast period.
The lower cost of excimer laser treatment in ophthalmology clinics and increasing preference amongst patients for visual abnormalities treatment in the ophthalmology clinics are driving the growth of this segment.
Similarly, a rise in the number of ophthalmic clinics across the world will further boost the growth of this segment during the assessment period.
The use of FLACS, or femtosecond laser-aided cataract surgery, as a safe and efficient therapy option for elderly patients, is rapidly gaining ground. Femtosecond lasers are replacing hand-held surgical instruments in procedures like cataract fragmentation, anterior capsulotomy, and corneal incision as a result of increased accuracy and precision.
Flapless treatments, like Small Incision Lenticule Extraction (SMILE), is being developed by major players in the excimer and femtosecond laser markets to treat refractive defects like myopia, hyper myopia, presbyopia, and astigmatism.
Similarly, various leading players are launching new products and using merger and acquisition strategies to gain a competitive edge in the global Excimer and Femtosecond Ophthalmic Lasers Market. For instance,
Attribute | Details |
---|---|
Estimated Market Size (2022) | US$ 1.18 billion |
Projected Market Size (2032) | US$ 2.41 billion |
Anticipated Growth Rate (2022 to 2032) | 8.0% CAGR |
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2014 to 2021 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA). |
Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The Rest of Latin America, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, The Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA. |
Key Market Segments Covered | Product, application, end user, region |
Key Companies Profiled | Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd. |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global Excimer and Femtosecond Ophthalmic Lasers Market is expected to reach US$ 1.18 billion in 2022.
The global sales of excimer and femtosecond ophthalmic lasers are anticipated to grow at 8% CAGR through 2032.
FMI predicts the global Excimer and Femtosecond Ophthalmic Lasers Market to reach a valuation of US$ 2.41 billion by 2032.
The increasing aging and diabetic population, rising number of people with refractive errors, and increasing number of ophthalmology clinics & hospitals are some of the factors driving demand for excimer and femtosecond ophthalmic lasers.
Refractive surgery application dominates the global Excimer and Femtosecond Ophthalmic Lasers Market with a total share of about 69.7%.
With around 32.2% market share in 2021, North America will continue to remain the most lucrative market for excimer and femtosecond ophthalmic lasers during the forecast period.
Abbott Medical Optics, Inc, Alcon Inc. (Novartis AG), Bausch Health Companies, ZEISS International NIDEK CO. LTD., are some of the leading companies in excimer and fetosecond ophthalmic laser market.
The USA., China, Canada, Japan, and India are the top 5 countries driving demand for excimer and femtosecond ophthalmic lasers.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Key Promotional Strategies By Manufacturers
4.3. Regulatory Landscape
4.4. Value Chain Analysis
4.5. Product Adoption Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Complexity of Healthcare Operations
5.2.3. Cost of products and treatments/surgeries
5.2.4. Availability of healthcare personnel
5.2.5. Rising Prevalence of Infections and Surgical Procedures
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Excimer and Femtosecond Ophthalmic Lasers Market Volume (Units) Analysis 2014 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2014 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Excimer and Femtosecond Ophthalmic Lasers Market - Pricing Analysis
8.1. Regional Pricing Analysis By Products
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Excimer and Femtosecond Ophthalmic Lasers Market Demand (in Value or in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2014 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032
10.3.1. Excimer Lasers
10.3.2. Femtosecond Lasers
10.4. Market Attractiveness Analysis By Product
11. Global Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Application, 2014 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
11.3.1. Refractive Surgery
11.3.2. Cataract Surgery
11.3.3. Capsulotomy
11.3.4. Trabeculoplasty
11.3.5. Diagnostic
11.4. Market Attractiveness Analysis By Application
12. Global Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By End User, 2014 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis Forecast by End User, 2022 to 2032
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Ophthalmology Clinics
12.4. Market Attractiveness Analysis By End User
13. Global Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2014 to 2021
13.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, By Region 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. The Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
14.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. The USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players Intensity Mapping
14.8. Country-Level Analysis & Forecast
14.8.1. The USA Excimer and Femtosecond Ophthalmic Lasers Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Canada Excimer and Femtosecond Ophthalmic Lasers Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
15. Latin America Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
15.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Excimer and Femtosecond Ophthalmic Lasers Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Brazil Excimer and Femtosecond Ophthalmic Lasers Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Argentina Excimer and Femtosecond Ophthalmic Lasers Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
16. Europe Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
16.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. The United Kingdom
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Nordic Countries
16.3.1.9. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. Germany Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Italy Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. End User
16.8.3. France Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. The United Kingdom Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
16.8.5. Spain Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Application
16.8.5.2.3. By End User
16.8.6. BENELUX Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Application
16.8.6.2.3. By End User
16.8.7. Russia Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Application
16.8.7.2.3. By End User
16.8.8. Nordic Countries Excimer and Femtosecond Ophthalmic Lasers Market Analysis
16.8.8.1. Introduction
16.8.8.2. Market Analysis and Forecast by Market Taxonomy
16.8.8.2.1. By Product
16.8.8.2.2. By Application
16.8.8.2.3. End User
17. East Asia Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market End User (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
17.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. China Excimer and Femtosecond Ophthalmic Lasers Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Excimer and Femtosecond Ophthalmic Lasers Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Excimer and Femtosecond Ophthalmic Lasers Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. South Asia Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
18.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Philippines
18.3.1.6. Vietnam
18.3.1.7. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. India Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Indonesia Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. Malaysia Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. Thailand Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
18.8.5. Philippines Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.5.1. Introduction
18.8.5.2. Market Analysis and Forecast by Market Taxonomy
18.8.5.2.1. By Product
18.8.5.2.2. By Application
18.8.5.2.3. By End User
18.8.6. Vietnam Excimer and Femtosecond Ophthalmic Lasers Market Analysis
18.8.6.1. Introduction
18.8.6.2. Market Analysis and Forecast by Market Taxonomy
18.8.6.2.1. By Product
18.8.6.2.2. By Application
18.8.6.2.3. By End User
19. Oceania Excimer and Femtosecond Ophthalmic Lasers Market 2014 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
19.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. Australia Excimer and Femtosecond Ophthalmic Lasers Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. New Zealand Excimer and Femtosecond Ophthalmic Lasers Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Excimer and Femtosecond Ophthalmic Lasers Market Analysis 2014 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2014 to 2021
20.3. Current and Future Market Value (US$ Million) and Volume (Unit) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Israel
20.3.1.5. North Africa
20.3.1.6. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Players Intensity Mapping
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Excimer and Femtosecond Ophthalmic Lasers Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application
20.8.1.2.3. By End User
20.8.2. Turkey Excimer and Femtosecond Ophthalmic Lasers Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application
20.8.2.2.3. By End User
20.8.3. South Africa Excimer and Femtosecond Ophthalmic Lasers Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Application
20.8.3.2.3. By End User
20.8.4. Israel Excimer and Femtosecond Ophthalmic Lasers Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Application
20.8.4.2.3. By End User
20.8.5. North Africa Excimer and Femtosecond Ophthalmic Lasers Market
20.8.5.1. Introduction
20.8.5.2. Market Analysis and Forecast by Market Taxonomy
20.8.5.2.1. By Product
20.8.5.2.2. By Application
20.8.5.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Bausch Health Company
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Abbott Medical Optics, Inc
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. Alcon Inc. (Novartis AG)
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. Bausch Health Companies
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. ZEISS International NIDEK CO. LTD.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. SCHWIND eye-tech-solutions GmbH & Co.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. IVIS TECHNOLOGIES EXCELSIUS MEDICAL GMBH Ziemer Ophthalmic Systems
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Ellex Medical Lasers Limited
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
22.3.9. Topcon Corporation
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Product Strategy
22.3.9.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports